Stevanato Group (NYSE:STVN) Director Karen Flynn Sells 1,493 Shares of Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Karen Flynn sold 1,493 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the transaction, the director directly owned 5,757 shares in the company, valued at approximately €98,387.13. The trade was a 20.59% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Stevanato Group Trading Down 0.2%

NYSE:STVN opened at €18.36 on Friday. The company has a 50-day moving average price of €17.41 and a 200-day moving average price of €17.26. Stevanato Group S.p.A. has a 12 month low of €12.89 and a 12 month high of €28.00. The company has a current ratio of 1.63, a quick ratio of 1.11 and a debt-to-equity ratio of 0.21. The stock has a market cap of $5.56 billion, a price-to-earnings ratio of 31.11, a P/E/G ratio of 1.59 and a beta of 0.78.

Stevanato Group (NYSE:STVN) last announced its earnings results on Friday, May 8th. The company reported €0.11 earnings per share for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). Stevanato Group had a net margin of 11.76% and a return on equity of 10.27%. The company had revenue of €273.57 million for the quarter. During the same quarter last year, the firm earned $0.10 earnings per share. The company’s quarterly revenue was up 6.6% on a year-over-year basis. Equities analysts predict that Stevanato Group S.p.A. will post 0.68 EPS for the current year.

Stevanato Group Cuts Dividend

The company also recently disclosed an annual dividend, which will be paid on Wednesday, July 29th. Shareholders of record on Thursday, June 11th will be given a dividend of $0.054 per share. This represents a yield of 31.0%. The ex-dividend date of this dividend is Thursday, June 11th.

Institutional Investors Weigh In On Stevanato Group

Hedge funds and other institutional investors have recently bought and sold shares of the business. Conestoga Capital Advisors LLC increased its stake in shares of Stevanato Group by 7.6% during the first quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after purchasing an additional 602,050 shares in the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in shares of Stevanato Group in the 4th quarter worth approximately $9,269,000. Norges Bank bought a new stake in shares of Stevanato Group in the 4th quarter worth approximately $8,185,000. Credit Agricole S A purchased a new stake in shares of Stevanato Group in the 3rd quarter worth approximately $9,785,000. Finally, T. Rowe Price Investment Management Inc. grew its stake in shares of Stevanato Group by 10.4% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after buying an additional 368,792 shares during the last quarter.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on STVN. Wolfe Research assumed coverage on Stevanato Group in a research report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 target price for the company. Citigroup dropped their price target on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a research report on Thursday, March 5th. Weiss Ratings raised Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, June 18th. TD Cowen upgraded Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Finally, KeyCorp lowered their price objective on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research report on Thursday, March 5th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy”.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.